I’m sure the company will dedicate all of their resources to ensuring an announcement is made to coincide with their annual general meeting in mid November. This will allow them to talk openly about their market plan during 2018 rather than what if and maybe scenarios….
I know there have been a couple of delays during the current trial although these delays were due to external parties. LCT has full control over analysis of this data with no reliance on external parties, because of this I’d be surprised if an announcement wasn’t made during November.
LCT Price at posting:
11.5¢ Sentiment: Buy Disclosure: Held
